Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Bullock

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Experimental Medicine|October 1, 1996
Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading framesT N Bullock, L C Eisenlohr
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic miceT N Bullock, T A Colella, V H Engelhard
Cancer Journal (Sudbury, Mass.)|June 30, 2000
Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their useV H Engelhard, T N Bullock, T A Colella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic miceT N Bullock, D W Mullins, T A Colella, et al.
Clinical Immunology and Immunopathology|December 24, 1997
Dinitrophenyl-modified autologous melanoma vaccine induces a T cell response to hapten-modified, melanoma peptidesT Sato, T N Bullock, L C Eisenlohr, et al.
The Journal of Experimental Medicine|October 7, 1997
Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expressionT N Bullock, A E Patterson, L L Franlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic miceD W Mullins, T N Bullock, T A Colella, et al.
The Journal of Experimental Medicine|April 5, 2000
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyT A Colella, T N Bullock, L B Russell, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Experimental Medicine|October 1, 1996
Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading framesT N Bullock, L C Eisenlohr
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic miceT N Bullock, T A Colella, V H Engelhard
Cancer Journal (Sudbury, Mass.)|June 30, 2000
Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their useV H Engelhard, T N Bullock, T A Colella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic miceT N Bullock, D W Mullins, T A Colella, et al.
Clinical Immunology and Immunopathology|December 24, 1997
Dinitrophenyl-modified autologous melanoma vaccine induces a T cell response to hapten-modified, melanoma peptidesT Sato, T N Bullock, L C Eisenlohr, et al.
The Journal of Experimental Medicine|October 7, 1997
Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expressionT N Bullock, A E Patterson, L L Franlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2001
Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic miceD W Mullins, T N Bullock, T A Colella, et al.
The Journal of Experimental Medicine|April 5, 2000
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyT A Colella, T N Bullock, L B Russell, et al.
Pageof 1